Identification of proliferating keratinocytes in middle ear cholesteatoma usingthe monoclonal antibody Ki-67

ORL

Volumn 58, Issue 1, 1996, Pages 23-26

  Bujía, Jesús ^a   Holly, Anja ^a   Sudhoff, Holger ^b   Antolí Candela, Francisco ^c   Tapia, Mario Guzman ^c   Kastenbauer, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Instituto ORL Antoli Candela   (Spain)

Author keywords

Cholesteatoma; Immunohistochemistry; Keratinocytes; Ki 67

Indexed keywords

CELL NUCLEUS ANTIGEN; MONOCLONAL ANTIBODY KI 67; PHOSPHATASE;

ARTICLE; BASAL CELL; BIOPSY; CELL PROLIFERATION; CHOLESTEATOMA; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MIDDLE EAR DISEASE; PRIORITY JOURNAL; SKIN; TISSUE SECTION;

EID: 0030032955     PISSN: 03011569     EISSN: 14230275     Source Type: Journal    
DOI: 10.1159/000276789     Document Type: Article

References (20)

1. Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E: Hyperproliferation-associated keratin expression in human middle ear cholesteatoma, Acta Otolaryngol (Stockh) 1993; 113: 364-368.
2. Bujia J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P: Aberrant expression of epidermal growth factor receptor in aural cholesteatoma, Laryngoscope 1993;103:326-329.
3. Schulz P, Bujia J, Holly A: Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor-alpha, Am J Otolaryngol 1993;14:82-87.
4. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, Int J Cancer 1983;31: 13-20.
5. Gerdes J, Lemke J, Baisch H, Wacher HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984:133:1710-1715.
6. Burger PC, Shibata T, Kleihues P: The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology, Am J Surg Pathol 1986; 10:611-617.
7. Stammberger M, Bujia J, Schilling V: Alteration of epidermal differentiation in middle ear cholesteatoma, Am J Otol, in press.
8. Camplejohn RS, Aheme WA: In vitro labelling of childhood cancers with tritiated thymidine, Br J Cancer 1974;29:487-489.
9. Hoshona T, Wilson CB: Cell kinetic analyses of human malignant brain tumors (gliomas), Cancer 1979;44:956-962.
10. Hoshino H, Nagashima T, Murovic JA: In-situ cell kinetics studies of human neuroectodermal tumors with bromodeoxyuridine labeling, J Neurosurg 1986:64:453-459.
11. Nagashima T, Dearnond SJ, Murovic J, Hoshino T: Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues, Acta Neuropathol (Berl) 1985:67:155-159.
12. Walker RA, Camplejohn RS: Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas, Br J Cancer 1988;57:281-284.
13. Ando M, Kawashima T, Kobayashi H, Ohka-wara A: Proliferating cells in the normal and psoriatic epidermis detected by Ki-67 monoclonal antibody, J Invest Dermatol 1989;92: 395.
14. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of HuKi-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections, J Pathol 1992;168:357-363.
15. Rijzewijk JJ, Groenendal H, Van Erp PEJ, Bauer FW: Two antigenic binding sites for Ki-67 related to quiescent and cycling cells in human epidermis, J Invest Dermatol 1987;89: 313.
16. Van Erp PEJ, Groenendal H, Bauer FW, Rijzewijk JJ: Growth fraction in epidermal skin disorders determined by the monoclonal antibody Ki-67. J Invest Dermatol 1987;89:313.
17. Miyauchi S, Hashimoto K, Miki Y: The innermost cell layer of the outer root sheath is positive Ki-67. J Invest Dermatol 1990;95:393-396.
18. Ahn JM, Huang CC, Abramson M: Localization of interleukin-1 in human cholesteatoma, Am J Otolaryngol 1990;11:71-77.
19. Schilling V, Negri B, Bujia J, Schulz P, Kastenbauer E: Possible role of interleukin-1 alpha and interleukin-1 beta in the pathogenesis of cholesteatoma of the middle ear, Am J Otol 1991;12:249-253.
20. Schilling V, Bujia J, Negri B, Schulz P, Kastenbauer E: Immunologically activated cells in aural cholesteatoma, Am J Otolaryngol 1992:12: 249-253.